1. Academic Validation
  2. Discovery of natural AMPK activator from the fruits of Xanthium sibiricum Patr.: Xanthiumine A, protoberberine alkaloid with unique C28 skeleton

Discovery of natural AMPK activator from the fruits of Xanthium sibiricum Patr.: Xanthiumine A, protoberberine alkaloid with unique C28 skeleton

  • Bioorg Chem. 2024 Jun 4:150:107527. doi: 10.1016/j.bioorg.2024.107527.
Tie Yao 1 Cuicui Tan 2 Yifang Rong 2 Shi Jie 2 Bingyang Zhang 2 Jiankun Yan 3 Shijie Cao 4 Feng Qiu 5
Affiliations

Affiliations

  • 1 State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China.
  • 2 School of Chinese Materia Medica, and Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China.
  • 3 College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050091, PR China.
  • 4 State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China. Electronic address: caoshijie@tjutcm.edu.cn.
  • 5 State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China; School of Chinese Materia Medica, and Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China. Electronic address: fengqiu20070118@163.com.
Abstract

Two Protoberberine Alkaloids with a unique C28 skeleton, named xanthiumines A (1) and B (2), respectively, were isolated from the fruits of Xanthium sibiricum Patr. Their structures including absolute configurations were unequivocally established by the comprehensive NMR and MS spectroscopic data analysis together with gauge-independent atomic orbital (GIAO) NMR calculations, and electronic circular dichroism (ECD) calculations. Compounds 1 and 2 are the first examples of natural protoberberine alkaloid with a phenolic acid group at C-13a. Their plausible biosynthetic pathway was proposed on the basis of the coexisting alkaloid monomer as the precursor. Furthermore, the effects and related molecular mechanism of compound 1 on hepatic lipid accumulation were also investigated in oleic acid (OA)-treated HepG2 cells.

Keywords

AMPK activator; C(28) skeleton; Lipid accumulation; Protoberberine alkaloids; Xanthium sibiricum.

Figures
Products